UBS Group AG - X4 PHARMACEUTICALS INC ownership

X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 99 filers reported holding X4 PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of X4 PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$155,577
+3075.7%
142,731
+5552.7%
0.00%
Q2 2023$4,899
-94.4%
2,525
-97.5%
0.00%
Q1 2023$87,000
+443.8%
100,000
+949.9%
0.00%
Q3 2022$16,000
+1500.0%
9,525
+684.0%
0.00%
Q2 2022$1,000
-50.0%
1,215
-3.8%
0.00%
Q1 2022$2,0000.0%1,263
+89.1%
0.00%
Q4 2021$2,000
+100.0%
668
+447.5%
0.00%
Q2 2021$1,000
-97.1%
122
-96.9%
0.00%
Q1 2021$34,000
-65.7%
3,990
-74.1%
0.00%
Q4 2020$99,000
+32.0%
15,422
+38.3%
0.00%
Q3 2020$75,000
+56.2%
11,149
+118.7%
0.00%
Q2 2020$48,000
-48.4%
5,098
-45.1%
0.00%
Q1 2020$93,000
-40.8%
9,283
-36.7%
0.00%
Q4 2019$157,000
+36.5%
14,668
+61.9%
0.00%
Q3 2019$115,000
+505.3%
9,059
+615.0%
0.00%
Q2 2019$19,000
+533.3%
1,267
+663.3%
0.00%
Q1 2019$3,0001660.00%
Other shareholders
X4 PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 6,247,500$6,809,7752.18%
Bain Capital Life Sciences Investors, LLC 15,960,588$17,397,0411.94%
Stonepine Capital Management, LLC 5,273,685$5,748,3171.91%
NEA Management Company, LLC 14,986,793$16,335,6041.26%
Sio Capital Management, LLC 2,599,003$2,832,9130.88%
New Leaf Venture Partners, L.L.C. 335,000$365,1500.47%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,973,683$2,151,3140.25%
Monashee Investment Management LLC 427,265$465,7190.20%
Orbimed Advisors 7,133,515$7,775,5310.16%
Parkman Healthcare Partners LLC 800,000$872,0000.16%
View complete list of X4 PHARMACEUTICALS INC shareholders